Published in Biotech Business Week, May 28th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Phylogica.
Report 1: Australian drug development company Phylogica Limited (ASX:PYC) today announced that it has received funding from the Neurotrauma Research Program to develop a new Phylomer drug that will prevent the brain damage associated with traumatic brain injury.
Traumatic Brain Injury (TBI) is caused by the head forcibly hitting an object, such as a car dashboard in a motor vehicle accident. In the United States, the direct cost of care for patients with TBI,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.